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ABSTRACT
Objective Examine the safety of menstrual cups against 
sanitary pads and usual practice in Kenyan schoolgirls.
Design Observational studies nested in a cluster 
randomised controlled feasibility study.
Setting 30 primary schools in a health and demographic 
surveillance system in rural western Kenya.
Participants Menstruating primary schoolgirls aged 
14–16 years participating in a menstrual feasibility study.
Interventions Insertable menstrual cup, monthly sanitary 
pads or ‘usual practice’ (controls).
Outcome measures Staphylococcus aureus vaginal 
colonization, Escherichia coli growth on sampled used 
cups, toxic shock syndrome or other adverse health 
outcomes.
Results Among 604 eligible girls tested, no adverse event 
or TSS was detected over a median 10.9 months follow-
up. S. aureusprevalence was 10.8%, with no significant 
difference over intervention time or between groups. Of 
65 S.aureus positives at first test, 49 girls were retested 
and 10 (20.4%) remained positive. Of these, two (20%) 
sample isolates tested positive for toxic shock syndrome 
toxin-1; both girls were provided pads and were clinically 
healthy. Seven per cent of cups required replacements 
for loss, damage, dropping in a latrine or a poor fit. Of 30 
used cups processed for E. coli growth, 13 (37.1%, 95% CI 
21.1% to 53.1%) had growth. E. coli growth was greatest 
in newer compared with established users (53%vs22.2%, 
p=0.12).
Conclusions Among this feasibility sample, no evidence 
emerged to indicate menstrual cups are hazardous or 
cause health harms among rural Kenyan schoolgirls, but 
large-scale trials and post-marketing surveillance should 
continue to evaluate cup safety.
INTRODUCTION
The inadequate management of adolescent 
girls’ menstruation in low/middle-income 
countries (LMIC) has recently emerged 
as an important priority for international 
action.1–5 Due to logistical and cost barriers, 
these females may manage menstruation with 
non-absorbent, unhygienic and uncomfort-
able materials.6–9 Studies in southern Asia 
and Africa report that such items are associ-
ated with genital infections although these 
are seldom clinically verified,10–12 preventing 
the understanding of women’s needs to mini-
mise such risks.2 6–8 13 Meanwhile, a growing 
body of pilot studies have embarked on 
testing the value of menstrual hygiene prod-
ucts, such as sanitary pads14–16 and menstrual 
cups,17–22 for girls and women in resource-
poor settings.
Although menstrual cups have not been 
associated with an increased risk of repro-
ductive tract and urogenital infections 
in women in high-income countries,23–28 
research on the safety of menstrual cups 
among girls17 19 21 and women18 20 in LMIC 
has relied on self-reported information 
with no clinical or laboratory confirmatory 
studies. There is a concern that an insert-
able menstrual item may increase the risk of 
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Strengths and limitations of this study
 ► In the small sample of girls followed, there was no 
evidence of health harms.
 ► Evaluation of the safety of menstrual products, 
including laboratory investigations, was feasible 
among adolescent schoolgirls in a low/middle-
income country (LMIC) setting.
 ► Logistical limitations prevented ‘before’ and ‘after’ 
prevalence surveys.
 ► To minimise the  possible health risks, girls were 
trained on how to use and clean menstrual cups, and 
girls in all arms were provided soap for handwashing, 
with follow-up by nurses, creating improved hygiene 
circumstances for cup use in this LMIC setting.
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infections, particularly Staphylococcus aureus, leading to 
menstrual toxic shock syndrome (mTSS).29 Tampons are 
linked to mTSS in women of reproductive age. Surveil-
lance data for the period 1979–1996 indicate that 5296 
cases were reported in women in the USA using highly 
absorbent tampons.30 The tampons were found to have 
been associated with vaginal microtrauma arising from 
the high absorbency.27 30–33 Menstrual cups which collect 
menstrual blood, however, are non-absorptive and do not 
disrupt the vaginal epithelium.27 28 Furthermore, among 
women using female barrier methods, which similarly 
uses medical grade silicone or latex products, mTSS 
is very low (~2.25 cases per 100 000 users per year).34 
Nevertheless, concern remains about any vaginal intru-
sion,29 35 36 particularly among girls,37 with poor water, 
sanitation and hygiene (WASH) facilities.38 Further labo-
ratory and field-based studies are, thus, needed to clarify 
risks associated with menstrual products to better define 
the cost-benefit of subsidised provision for girls in LMIC. 
This paper describes the exploration of cup safety during 
a randomised controlled pilot feasibility study among 
adolescent schoolgirls in rural Kenya.39
METHODS
Study site and population
The study site is within the health and demographic 
surveillance system (HDSS) of the Kenya Medical 
Research Institute (KEMRI) and CDC research station in 
Siaya County, a rural district in the former Nyanza Prov-
ince, in western Kenya.40 The population of the HDSS 
site approximates 230 000 individuals in a ~700 km2 area, 
with adolescent girls aged 15–19 years comprising ~11% 
of the female population.40 The area is served by 1 district 
hospital providing tertiary care and 10 local health clinics 
within the HDSS area. A second district hospital is sited in 
Kisumu, 40 km from the study site. The KEMRI and CDC 
collaborative research station has on-site laboratories 
certified for clinical trials and quality control procedures.
Menstrual Solutions study
The Menstrual Solution study was a cluster randomised 
controlled 3-arm ‘proof of concept’ feasibility study 
conducted in Gem, a subarea within the HDSS.39 Of 71 
primary schools in Gem, 62 agreed to participate in a base-
line water sanitation and hygiene (WASH) assessment. 
Of these, 30 reached the pre-defined WASH threshold 
(presence of water in school on the day of WASH visit, 
availability of separate latrine bank for girls and a pupil:la-
trine ratio of 70:1 or less) described in detail elsewhere.38 
All girls in the 30 study schools were eligible if they were 
aged 14–16 years, had experienced 3 menses, were resi-
dent in the HDSS for at least 4 months and attended a 
study school (figure 1).39 A sample of 185 girls/arm was 
estimated to offer 5% precision for the primary outcome, 
(school dropout) if this occurred in 15% of the control 
arm.39 Recruitment of 250 girls (10 schools, average of 25 
girls per school) was scheduled to allow for a design effect 
of 1.25% and 7.5% loss to follow-up. Girls were enrolled 
from August 15, 2012 to August 27, 2013 and followed 
until November 21, 2013, with a median (IQR) follow-up 
time of 10.9 (6.1–12.5) months. Further details of the 
overall study methods are published elsewhere.39
Menstrual products and hygiene
Girls in the menstrual cup group were provided with 
one menstrual cup (Mooncup), size B for nullipa-
rous women or size A for those who had given birth 
(figure 2). This brand was selected because it has been 
tested internationally,26 41 registered by the US Food 
and Drug Administration  and by the Kenyan Pharmacy 
and Poisons Board for pilot testing among schoolgirls in 
Nairobi.19 Cups are made of high-grade medical silicone 
with material continuous without edges.25 When inserted 
into the vagina, it collects ~30 mL of menstrual blood, 
lasting 4–8 hours before emptying is required, according 
to the manufacturer. Girls in the cup group were given 
instruction on how to insert, remove and clean the cup. 
Girls in the sanitary pad arm were each given two packs 
(total 16 pads) monthly of Always, a brand available in 
Kenya. Girls in the usual practice group continued using 
traditional materials, such as cloths, bedding or paper2 22 
or sanitary pads. All participating girls, regardless of study 
arm, received a lesson on menstrual hygiene by study 
nurses, including hand-washing and how to wipe after 
defecation, and provision of bar soap for hand hygiene 
throughout the study. Schools separately received soap 
detergent to support pupils’ hand-washing in school.
Safety monitoring
Safety monitoring components comprised routine nurse-
based screening, population-based monitoring (figure 3) 
and clinical evaluation of infection with laboratory confir-
mation.
Nurse screening and population-based monitoring
Following a meeting with the girls and parents, each family 
was provided with information leaflets which included 
signs and symptoms of mTSS, where they could seek 
emergency care and contact information. Possible mTSS 
was monitored through school and community pathways. 
Study nurses screened each participant routinely twice per 
term, asking girls about comfort of the product, use and 
any health concerns including questioning of mTSS signs 
and symptoms. This was supplemented by nurse visits to 
their designated target schools one to two times a week, 
allowing examination of any participant complaining of 
any signs or symptoms that could be mTSS or another 
infection or harm. A focal point teacher designated by 
girls in each school was provided credit for her phone 
to communicate with nurses between visits, if necessary. 
Field staff were informed of all girls participating in the 
study who resided in their designated village. All partic-
ipants and their families were provided contact details 
of the field staff in their village, in case they wished to 
contact them in the event of a febrile episode or any 
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other symptoms that could have been mTSS. The field 
staff were provided contact information for the study 
nurses and research team, and could support immediate 
evacuation to tertiary care facilities, if required.
The hospitals and health facilities in the study area were 
provided with leaflets on clinical signs and symptoms of 
mTSS. Consultant obstetrician and gynaecologists in 
tertiary care facilities were involved with the study and 
were prepared to accept any mTSS referral cases during 
the study duration. At the end of the study, nurses visited 
all health facilities in the study area to recheck registry 
records as a precaution against any case missed by our 
monitoring procedures. The study data manager reviewed 
the HDSS database for deaths of any study participants 
on a monthly basis, and completed a summary check at 
study end to enumerate and confirm if any deaths had 
occurred or been missed from the monthly surveillance 
checks.
Vaginal swabbing to evaluate the prevalence of S. aureus
Assenting girls in all groups were invited to have a vaginal 
swab to examine the prevalence of S. aureus colonisation 
between January and September 2013. After piloting the 
procedure, each nurse facilitated the S. aureus study in 
her schools, training the girls on the self-swabbing proce-
dure.42 The self-collected vaginal swab (BBL Culture swab, 
COPLAN for Becton Dickinson) was conducted by girls 
in a school bathroom or private room. Participants were 
taught to insert the swab into the endocervical canal and 
stop when the tip was no longer visible. As instructed, the 
girls would then rotate the swab three to five times inside 
the vagina, withdraw it but avoid contact with vaginal 
surfaces, and put the swab in the tube (containing Ames 
Figure 1 Participants' flow diagram for Menstrual Solution study and Staphylococcus aureus survey.
Figure 2 Menstrual cup distributed to girls in cup-
allocated schools.
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transport media with agar), break the handle of the swab 
and close the tube tightly. Swabs were not taken during 
menstruation.29 42–44 The girls gave the vaginal swab to 
the nurse who checked whether it was moist/discoloured 
before placing it in a phial containing Amies transport 
medium with agar (Becton Dickinson Microbiology 
Systems). Each phial was labelled individually with the 
girls' unique study code, and placed in a cool box packed 
with frozen ice packs, and shipped to the KEMRI labo-
ratories for isolation and phenotypic identification of S. 
aureus and TSST-1 production. Swabs were transported on 
the same day, within 6 hours of collection, to the KEMRI 
laboratory, and stored at −70°C to −80°C before testing.
Swab analysis for S. aureus
Laboratory staff were masked to girls’ allocated 
menstrual product. Each vaginal swab was processed as 
per protocol.27 29 Swabs were streaked for isolation onto 
a mannitol salt agar plate and on tryptic soy agar with 5% 
sheep blood. All plates were incubated between 36°C and 
37°C for 24 hours in air. After incubation, colony types 
were visualised for characteristic morphology of S. aureus. 
Colonies were enumerated, isolated on plates containing 
tryptic soy agar, and incubated for 24 hours between 36°C 
and 37°C. Gram staining, a catalase test, and a slide and 
tube coagulase test were performed to phenotypically 
identify S. aureus.
Detection of TSST-1 among S. aureus-positive girls
This required a second (repeat) positive swab taken from 
girls found positive in the main prevalence survey. Repeat 
swabs from S. aureus-positive girls were processed as above, 
and examined again for the presence of S. aureus. After 
positive identification as S. aureus via culture (required 
for toxic shock syndrome toxin-1 (TSST-1) testing), 
isolates were placed in sterile (16 mm by 150 mm) glass 
tubes containing 5 mL of brain heart infusion broth 
(Becton Dickinson), and tubes were mixed end over end 
for 18–24 hours at 36°C–37°C in a shaking incubator. 
Samples were pelleted by centrifugation (900 g for 20 min 
at 4°C) and the supernatant placed into microcentrifuge 
tubes. The Toxic Shock Test-Reverse Passive latex Antigen 
(TST-RPLA) agglutination test for the detection of TSST-1 
in the culture fluid supernatant of the cultured S. aureus 
was tested using the staphylococcal test kit (TD0940A).
Menstrual cup screening for Escherichia coli contamination
Data from all girls receiving cups were assessed and 1:4 
cups were randomly selected stratified by duration of 
provision, excluding girls who had received a replacement. 
Randomly selected participants were traced and asked if 
they were willing to swap their existing cup for a new one, 
to allow laboratory examination of their cup. Each used 
cup was placed in a separate lock-bag, which was labelled 
with girls’ study code, and transported to the laboratory 
and tested for E. coli growth. Each cup was swabbed using 
a polyester tipped swab moistened in normal saline and 
inoculated into both MacConkey (MAC) agar and onto 
blood agar and incubated for 18–24 hours at 37°C. After 
incubation, colony types were visualised for characteristic 
morphology of E. coli from the MAC plates and subjected 
to indole testing. The colonies generated which were 
indole positive were classified using standard terminology 
Figure 3 Flow diagram for action of suspected menstrual toxic shock syndrome event. AK, Aga Khan; FP, focal point; TSST, 
toxic shock syndrome toxin;VR, village recorder (field staff).
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as suspected E. coli.45 Laboratory outcomes were analysed 
by study arm, into proportion positive, with 95% confi-
dence limits.
Data analysis
Participant characteristics gathered through girls’ 
self-completed surveys on notebooks, intervention imple-
mentation by date of provision and duration of follow-up 
by study nurses, and laboratory results were aggregated 
by participant ID, and prevalence values analysed using 
SPSS version 21.0. The prevalence of E. coli on cups was 
calculated with 95% CIs. Means and medians were calcu-
lated with corresponding SD and the IQR. Significant 
differences in prevalence and linear trends were tested 
using χ2.
RESULTS
Of 1005 girls in the 30 study schools in eligible classes, 
199 (19.8%) were ineligible, 40 (5.0%) girls refused, and 
15 (1.8%) migrated before intervention (figure 1). Of 
the 751 receiving intervention, 11 were pregnant prior 
to intervention and 96 (12.8%) were lost to follow-up 
providing 644 girls for outcome evaluation.39 Of these, 
604 contributed towards the population surveyed for S. 
aureus, and 40 girls were not swabbed (18 had dropped 
out and 22 were absent at the time of survey).
Participant characteristics
The mean (SD) age of participants at enrolment was 14.6 
(0.7) years, and mean age at menarche was 13.6 (0.9) 
years (table 1). Menses lasted for a mean of 3.8 (1.3) 
days, with most girls (82.6%) reporting they had ever 
used pads, but none used tampons or menstrual cups. A 
quarter reported having ever had sex, there were 4 preg-
nancies and 12 stated they were married.
Morbidity and mortality surveillance
No symptoms of mTSS were identified during nurse 
screening or reported through village recorders. No cases 
of mTSS were identified or referred to tertiary care facilities. 
The health clinic records review identified no participants 
attending health services for febrile episodes or any other 
symptom of mTSS. HDSS census review monthly and at end 
study identified no deaths among our study participants. 
At nurse routine screening, 10 girls (5 pads and 5 cups) 
reported heavy bleeding, 80% of whom had reported this 
preintervention. These girls were referred to tertiary care 
facilities, where the consultant gynaecologist reported no 
abnormal findings, but provided haematinics.
S. aureus prevalence survey
Of 604 vaginal swabs collected among eligible partic-
ipants, S. aureus was detected in 65 (10.8%) samples 
(table 2). When stratified by duration of intervention, 
S. aureus prevalence was 13.0% in the first intervention 
month, with no statistically significant trend between 
groups (10.5% cups, 13.6% pads, 15.2% controls; χ2 
linear trend=0.34, p=0.56). Prevalence during interven-
tion follow-up, after a median of 4 months (range 2–11 
months) was 10.2%, with no significant trend between 
groups (9.4% cups, 10.7% pads, 10.5% controls; χ2 linear 
trend=0.09, p=0.76). There was no significant difference 
in prevalence between early intervention and during use, 
overall or within groups (table 2).
Toxic shock syndrome toxin (TSST)−1
In the first batch of 65 participants with vaginal swabs 
positive for S. aureus, 49 girls were available to collect a 
Table 1 Characteristics of study population*
Characteristics
Statistics/
category
Control, %
(n=200)
Pads, %
(n=256)
Cups, %
(n=188)
Total, %
(n=644)
Age in years at enrolment Mean (SD) 14.6 (0.7) 14.5 (0.7) 14.6 (0.7) 14.6 (0.7)
Age in years at menarche Mean (SD) 13.6 (0.8) 13.7 (0.8) 13.5 (1.0) 13.6 (0.9)
Number of days of menses Mean (SD) 3.7 (1.2) 3.9 (1.3) 3.7 (1.5) 3.8 (1.3)
Experience heavy periods Yes 41 (20.5%) 68 (26.6%) 39 (20.7%) 148 (23.0%)
Experience period cramps Yes 129 (64.5%) 165 (64.5%) 115 (61.2%) 409 (63.5%)
Ever used pads Yes 168 (84.0%) 198 (77.3%) 166 (88.3%) 532 (82.6%)
Ever had sex† n 194 249 183 626
Yes 47 (24.2%) 58 (23.3%) 58 (31.7%) 163 (26.0%)
Ever been pregnant n 194 249 183 626
Yes 0 (0%) 2 (0.8%) 2 (1.1%) 4 (0.6%)
Report being married n 194 249 183 626
Yes 3 (1.5%) 4 (1.6%) 5 (2.7%) 12 (1.9%)
Duration of follow-up Median (IQR) 10.5 (5.6–12.5) 11.4 (6.7–12.5) 10.9 (5.0–12.6) 10.9 (6.1–12.5)
*Characteristics reported by 644 participants at baseline survey.39
†626 of 644 answered questions on sex, pregnancy and marriage; ever had sex includes girls reporting having had sexual intercourse, 
including those reporting tricked or forced to have sexual intercourse; n - number who answered question.
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second swab to examine the presence of TSST-1. Of these 
swabs, 10 (20.4%) yielded S. aureus. These second-level 
swabs were immediately processed to examine the pres-
ence of TSST-1 toxin. Of these 10, 2 (20%) tested positive 
for TSST-1. Neither of these was a girl provided with a 
menstrual cup; both were in the sanitary pad group. 
Study participants were followed up, including these two 
girls, and found to be healthy and asymptomatic.
Menstrual cup loss or damage
Of 188 girls followed to outcome, 14 (7%) girls required 
replacement cups due to cup loss (3 participants, 
including 1 girl twice), damage (two cups: one burned 
when boiling and one eaten by rats), too small (three cups, 
replaced with size A due to leaking) or dropped inside the 
latrine (six cups). Examination of cups during screening 
revealed only minor abrasions or small damage to tail 
ends when cut to size.
E. coli growth on used menstrual cups
Of 188 girls provided cups and followed to outcome, 21 
dropped out. Of the 167 non-dropouts, a sampling frame 
was obtained from the nurse’s follow-up survey data-
base in the last study quarter. This comprised 134 girls 
surveyed, with 33 girls missed due to non-attendance. 
From this sample of 134 girls, a random selection of 1 in 4 
cups (35, 26%) were randomly selected. No girls refused. 
Duration of provision was used to stratify the 35 cups, 
with 17 representing new cup users provided cups for 
less than 6 months and 18 established cup users provided 
for 6 months or longer (table 3). Five unused cups acted 
as controls. Of the 40 cups processed, there was no E. 
coli on control cups, whereas 13 of 35 used cups had 
E. coli growth (37.1%, 95% CI 21.1% to 53.1%; table 3). By 
duration of cup provision, the prevalence of E. coli growth 
generated was greatest in newer users, with growth on 9 of 
17 (53%, 95% CI 29.3% to 76.7%) cups compared with 4 
of 18 (22.2%, 95% CI 2.9% to 41.1%) cups of established 
users, a difference of 31% (p=0.12). Examination of E. coli 
growth by girls’ age, socioeconomic status, reported ever 
used pads, age at menarche, duration of bleeding and if 
periods were reported to be heavy only found an associ-
ation with heavy periods; 61.5% of girls reporting heavy 
periods had E. coli on cups, compared with 22.7% of those 
stating they did not have heavy periods (p=0.022).
DISCUSSION
We observed 10.8% prevalence of S. aureus in 14- to 
16-year-old girls in this area. This is at the lower range 
Table 2 Prevalence of Staphylococcus aureus early and during intervention by study group
First month 
intervention
Greater than 1 
month intervention Total study χ2 p-Value
Cups 4/38 (10.5) 13/139 (9.4) 17/177 (9.6) 0.05 0.83
Pads 6/44 (13.6) 21/197 (10.7) 27/241 (11.2) 0.32 0.57
Control 5/33 (15.2) 16/153 (10.5) 21/186 (11.3) 0.6 0.44
Total 15/115 (13.0) 50/439 (10.2) 65/604 (10.8) 0.77 0.38
χ2 linear trend 0.34 0.09 0.26
p-value 0.56 0.76 0.61
Table 3  Escherichia coli growth generated on cups over differing time spans
Total cups 
available* 
population 
represented
Cups randomly
sampled
Proportion cups 
from available 
sample,%
Number with E. 
coli growth
Prevalence,% 
(95% CI)
New <2 m use 14 6 3 50 (10.0 to 90.0)
3–5 m use 51 11 6 55 (25.6 to 84.4)
All new users 
(<6 m)
65 17 25 9 53 (29.3 to 76.7)
Long term Established 
(6–9 m)
58 12 4 33.3 (6.6 to 60.0)
Longer term 
(9 m>)
11 6 0 0
All long-term 
users (6 m>)
69 18 26 4 22.2 (2.9 to 41.1)
134 35 26 13 37.1 (21.1 to 
53.1)
*Available population at cup-check in last study quarter.
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of the 10%–20% vaginal carriage rate reported in the 
general population in high-income countries.29 46 We 
found no statistical difference in the prevalence of S. 
aureus detected at first introduction and during interven-
tion with cups and pads, with no significant difference 
between study groups. No cases of mTSS were detected, 
and TSST-1 was not found among girls using cups with 
laboratory confirmed S. aureus colonisation. No harms 
were detected although E. coli was grown on a third of 
used cups.
To our knowledge, no other studies have evaluated the 
safety of menstrual products among schoolgirls in LMIC 
settings. This study demonstrated the feasibility of such 
evaluations, and that testing laboratory evaluations can 
be conducted to ensure rigour. However, as a feasibility 
study, a number of limitations are evident. For logistic 
reasons, we were unable to conduct complete sampling 
for a ‘before’ and ‘after’ S. aureus prevalence survey. 
Although sampling at different stages may have introduced 
bias, we detected no difference in prevalence between 
girls sampled early during intervention, compared with 
later or between study groups, and the point prevalence 
remained within the ‘expected’ range.47 Only a small 
proportion of S. aureus positives were identified positive 
on second testing, leaving few10 samples for isolation of 
TSST-1, preventing analysis of risk factors. S. aureus was 
only detected in 20% of girls who had been positive at first 
screening, when swabbing was repeated. Transience is a 
recognised phenomenon in vaginal carriage, with higher 
persistence in nasal than vaginal carriage.47 Colonisation 
also varies according to the time of the menstrual cycle 
due to altered levels of iron, pH, oxygen, carbon dioxide, 
redox potential and/or osmolarity.29 48 49 While we found 
no adverse events among the participants followed, 10% 
of girls migrated out of the study area. The HDSS system 
allowed us to visit all homes with no cases of TSS reported 
from these families. We assessed all health clinic registers, 
reviewing girls by name, and no TSS cases were found. If a 
girl was registered under a different name, we would have 
missed this; however, no cases of mTSS were diagnosed, 
and our HDSS census identified no study participant had 
died. We note, however, mTSS is rare and our popula-
tion studied was small. We used indole test to generate 
E. coli growth45; confirmatory tests would more accurately 
assess contamination risk of E. coli,50 which we assume 
would have been equally distributed across groups strat-
ified by time. We did not consider evaluating E. coli on 
pads or cloths, which in hindsight may have provided an 
important comparison.
Interpretation
Studies in high-income countries have shown menstrual 
cups to be safe and effective. Post-marketing surveil-
lance of over 100 million soft menstrual cup users, and 
examination of vaginal pH and microflora, urinalysis, 
pap smears and colposcopy in 406 subjects using cups 
for 3 months found no evidence of adverse effects 
among menstrual cup users.28 One study examined 
whether menstrual cups act as a fomite for S. aureus or 
are conducive to contamination with TSST-1; no asso-
ciation was found.27 Our surveillance did not detect 
mTSS among participants using menstrual cups or other 
menstrual care items. mTSS is a rare condition with a 
risk of 1–16 cases per 100 000 women-years and has a 
lower mortality than non-menstrual TSS, it may still be 
life threatening.51 Menstrual TSS requires vaginal colo-
nisation with a toxin-producing strain of S. aureus in the 
vagina during menstruation, in the absence of a posi-
tive antibody (titer of 1:32).47 TSST-1 is a super antigen, 
causing an exaggerated release of inflammatory cyto-
kines responsible for the symptoms of clinical disease.47 
It is believed that mTSS develops from a site of colo-
nisation rather than from infection.29 36 In our study, 
TSST-1 toxin was detected in 2 of 10 S. aureus isolates, 
a prevalence of 20% in girls with persistent S. aureus, 
similar to the range detected in other studies.52–54 The 
two girls, both in the sanitary pad arm with no access to 
menstrual cups, were healthy and did not exhibit any 
sign or symptom of mTSS. Other studies have shown 
the presence of TSST-1 detected among healthy individ-
uals with protective antibody titers (>100).55 One case 
of mTSS has been reported in Canada in a woman with 
Hashimoto thyroiditis, an autoimmune disease, within 
10 days of her first cup use.56 Further surveillance of 
mTSS among users is, thus, warranted.
E. coli growth was detected on a third of cups, with 
the greatest proportion among girls who had been 
allocated cups within 6 months. Separate questioning 
of girls revealed dropping of cups occurred more 
frequently in early use.57 Inexperienced girls reported 
difficulty changing and emptying in school where locks 
were absent from latrine doors, and conditions were 
cramped and unlit with the stress of other girls waiting 
outside to use the latrine.57 School eligibility required a 
threshold of 70 pupils or less per latrine, separate toilets 
for girls and water observed at baseline in this study.38 
We note in a separate paper that hand-washing was 
reported more commonly among girls using cups than 
the other groups, suggesting nurse training and caution 
about cup hygiene was understood by girls.58 However, 
other studies show girls’ inability to adequately clean 
themselves after defecation, resulting in vaginal contam-
ination with 10 different micro-organisms including 
E. coli.59 However, we were unable to also swab girls to 
assess the presence of vaginal E. coli, and thus cannot 
infer that E. coli on cups would be associated with 
vaginal E. coli. Our research supported the hygienic 
use of all menstrual products, with intense monitoring 
of all participants over time. We recommend further 
studies examining the vaginal microbiome among 
menstrual cup users, include vaginal E. coli, as a study 
reported an association between vaginal E. coli and low 
birth weight.60 We, thus, offer caution to programmes 
embarking on menstrual cup or pad distribution to 
ensure adequate safety procedures, including infor-
mation, education and communication are provided 
group.bmj.com on May 24, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
8 Juma J, et al. BMJ Open 2017;7:e015429. doi:10.1136/bmjopen-2016-015429
Open Access 
to girls, and support of WASH infrastructure in their 
schools.61 Similarly, we note provision of hygiene 
supplies and follow-up of nurses improved the hygienic 
circumstances for cup use in this LMIC setting.
CONCLUSIONS
To our knowledge, no studies have evaluated the safety 
of menstrual products used by schoolgirls in LMIC. 
In this study, we did not detect harms associated with 
menstrual cups use among adolescent schoolgirls in 
this rural African setting. The vaginal colonisation rate 
of S. aureus was within the range of published data, and 
similarly we observed only a 20% rate of TSST-1 among 
girls with persistent S. aureus colonisation, with no direct 
association with menstrual cups. Further studies such 
as large-scale trials and post-marketing surveillance are 
recommended to verify findings from this feasibility 
study. Studies are required to further strengthen meth-
odological approaches used in LMICs. Presence of E. 
coli grown on a quarter of sampled cups and higher 
rates among new users, despite substantive education 
by study nurses, suggests hygiene education and WASH 
infrastructures in schools needs to be strengthened,62 63 
and cup provision requires a strong educational compo-
nent.
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